The role of miR-342-3p in myocardial fibrosis of chronic heart failure by targeting CRIM1

Chronic heart failure (CHF) is characterized by myocardial fibrosis as its core pathological feature, yet effective therapeutic targets for this process remain limited. A total of 85 CHF patients and 73 healthy controls were included to measure the expression of miR-342-3p and CRIM1 in peripheral blood and to evaluate their clinical relevance. In in vitro experiments, miR-342-3p mimics and CRIM1 overexpression were used to functionally assess TGF-β1-induced fibrosis in human cardiac fibroblasts. Comprehensive experiments, including qPCR, CCK-8, Transwell, and dual-luciferase reporter assays, demonstrated that miR-342-3p regulates fibroblast proliferation, migration, and the expression of fibrosis-related genes by targeting CRIM1. Clinical analysis indicates that peripheral blood miR-342-3p expression in CHF patients is significantly lower than in healthy controls, while CRIM1 expression is significantly higher. Both are associated with clinical indicators such as heart function classification, BNP, LVEF, and LAVI. miR-342-3p showed potential diagnostic value for CHF, and its low expression was associated with an unfavorable prognosis. In vitro experiments found that TGF-β1 inhibits miR-342-3p expression, while overexpression of this miRNA promotes cell proliferation and migration and reduces the levels of fibrosis markers. Mechanistically, CRIM1 has been confirmed as a direct target of miR-342-3p, mediating its anti-fibrotic effect. miR-342-3p is downregulated in CHF and inhibits cardiac fibrosis by targeting CRIM1, suggesting that it may serve as a novel diagnostic marker and potential therapeutic target for CHF.

Authors

Institutions

Publication Details

Journal
Journal of Cardiothoracic Surgery
Published
2026-11-17
DOI
https://doi.org/10.1186/s13019-026-04779-2
Primary Topic
Cardiac Fibrosis and Remodeling
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The role of miR-342-3p in myocardial fibrosis of chronic heart failure by targeting CRIM1

Rong Wang, Xingxing Ren, Yahui Wang, Xiaoxiao Li et al.
Journal of Cardiothoracic Surgery
Cardiac Fibrosis and Remodeling
article

The role of miR-342-3p in myocardial fibrosis of chronic heart failure by targeting CRIM1

Rong Wang, Xingxing Ren, Yahui Wang, Xiaoxiao Li, Ting Li
article en

Abstract

Chronic heart failure (CHF) is characterized by myocardial fibrosis as its core pathological feature, yet effective therapeutic targets for this process remain limited. A total of 85 CHF patients and 73 healthy controls were included to measure the expression of miR-342-3p and CRIM1 in peripheral blood and to evaluate their clinical relevance. In in vitro experiments, miR-342-3p mimics and CRIM1 overexpression were used to functionally assess TGF-β1-induced fibrosis in human cardiac fibroblasts. Comprehensive experiments, including qPCR, CCK-8, Transwell, and dual-luciferase reporter assays, demonstrated that miR-342-3p regulates fibroblast proliferation, migration, and the expression of fibrosis-related genes by targeting CRIM1. Clinical analysis indicates that peripheral blood miR-342-3p expression in CHF patients is significantly lower than in healthy controls, while CRIM1 expression is significantly higher. Both are associated with clinical indicators such as heart function classification, BNP, LVEF, and LAVI. miR-342-3p showed potential diagnostic value for CHF, and its low expression was associated with an unfavorable prognosis. In vitro experiments found that TGF-β1 inhibits miR-342-3p expression, while overexpression of this miRNA promotes cell proliferation and migration and reduces the levels of fibrosis markers. Mechanistically, CRIM1 has been confirmed as a direct target of miR-342-3p, mediating its anti-fibrotic effect. miR-342-3p is downregulated in CHF and inhibits cardiac fibrosis by targeting CRIM1, suggesting that it may serve as a novel diagnostic marker and potential therapeutic target for CHF.

Journal of Cardiothoracic Surgery
Capital Medical University (CN), Ganzhou People's Hospital (CN), Ezhou Central Hospital (CN), Nanfang Hospital (CN), Southern Medical University (CN)
Cardiac Fibrosis and Remodeling
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon